Abstract:Smoking and chronic stress are well-documented risk factors that are associated with beta-adrenoceptors in the development of pancreatic cancer. Stimulation of beta-adrenoceptors can activate cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) and mitogen-activated protein kinase (MAPK) pathways in pancreatic cancer cells. Many recent studies have focused on the function of beta-adrenoceptors in cancer invasion. Thus, we hypothesized that beta-adrenoceptors may play a role in pancreatic cancer invasion, and beta-blockers may suppress the pancreatic cancer invasion and proliferation. MIA PaCa-2 and BxPC-3 cell lines express mRNA and protein of both beta(1) and beta(2)-adrenoceptors. beta(2)-adrenergic antagonist IC111B(t)551 and beta(1/2)-adrenergicantagonist propranolol significantly suppressed cell invasion and proliferation in comparison to beta(1)-adrenergic antagonist metoprolol and control in a Matrigel invasion assay and subrenal capsular assay. Treatment with beta(2)-adrenoceptor antagonists inhibited activation of transcription factors nuclear factor kappa B (NF kappa B), activator protein 1 (AP-1) and cAMP response element binding protein (CREB) as demonstrated by electrophoretic mobility shift assays and western blotting. beta(2)-adrenoceptor antagonists also significantly altered vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2), matrix metalloproteinase 2 (MMP-2) and MMP-9 expression. The beta(2)-adrenergic antagonists suppressed invasion and proliferation by inhibiting both cAMP/PKA and Ras, which regulate activation of the MAPK pathway and transcription factors, such as NF kappa B, AP-1 and CREB, as well as expression of its target genes, MMP-9, MMP-2 and VEGF. However, beta(1)-adrenergic antagonists suppressed invasion by inhibiting only the cAMP/PKA pathway, suggesting that they may be useful as novel preventive and therapeutic strategies for pancreatic cancer.

Inhibition Of Pancreatic Cancer Cell Proliferation By Propranolol Occurs Through Apoptosis Induction The Study Of Beta-Adrenoceptor Antagonist'S Anticancer Effect In Pancreatic Cancer Cell

Inhibition of Pancreatic Cancer Cell Proliferation by Propranolol Occurs Through Apoptosis Induction: The Study of β-Adrenoceptor Antagonist's Anticancer Effect in Pancreatic Cancer Cell

Suppression of human pancreatic cancer cell proliferation by β-adrenoceptor antagonists via induction of apoptosis in vitro

Inhibition of human pancreatic cancer by β2-adrenergic antagonist via suppression of invasion

The Β-Adrenoceptor Antagonist, Propranolol, Induces Human Gastric Cancer Cell Apoptosis and Cell Cycle Arrest Via Inhibiting Nuclear Factor Κb Signaling.

Effect of propranolol on the proliferation,apoptosis and cell cycle of gastric carcinoma cells

Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells

Parthenolide Induces Proliferation Inhibition and Apoptosis of Pancreatic Cancer Cells in Vitro

Effects of Α-Adrenoreceptor Antagonists on Apoptosis and Proliferation of Pancreatic Cancer Cells in Vitro

beta(2)-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF kappa B and AP-1

Prevention of pancreatic cancer by the beta-blocker propranolol

Propranolol Induced G0/G1/S Phase Arrest and Apoptosis in Melanoma Cells Via AKT/MAPK Pathway

Propranolol Suppresses Bladder Cancer by Manipulating Intracellular Ph Via NHE1

β 2-adrenoceptor blockage induces G 1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway

Norepinephrine-induced Invasion by Pancreatic Cancer Cells is Inhibited by Propranolol

Effects of Propranolol in Combination with Radiation on Apoptosis and Survival of Gastric Cancer Cells in Vitro

Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity

Abstract 2992: Propranolol Induces G0/G1/S Phase Arrest and Apoptosis in Melanoma Cells Via AKT/MAPK Pathway

The Apoptosis of Human Pancreatic Cancer Induced by ICI118,551 and Its Mechanism of Action

Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis

Synthetic small peptides acting on B7H1 enhance apoptosis in pancreatic cancer cells.